Guillaume Pfefer, CEO of Senda Biosciences & »Æ¹ÏÊÓƵapp CEO-Partner, describes Senda’s work to unlock comprehensive programming of medicine and what is in store for the company in the year ahead. More from Flagship @ JPM2023 here.
More from:
Human Health
Three Questions with Hari Pujar, Founding President of Mirai Bio and Flagship Operating Partner
The Next Generation of Biologics Are Supranatural
Three Questions with Volker Herrmann, Flagship CEO-Partner & CEO of Sonata Therapeutics
Pioneering Profile
Q&A with Molly Gibson on Leading Company Origination
Letter of Support